These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38061502)

  • 1. Discrepancies Between the Electronic Medical Record and Website Access to the Prescription Drug Monitoring Program.
    Itzep N; Campbell U; Madden K; Bruera E
    J Pain Symptom Manage; 2024 Mar; 67(3):e251-e253. PubMed ID: 38061502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid Prescribing After Implementation of Single Click Access to a State Prescription Drug Monitoring Program Database in a Health System's Electronic Health Record.
    Weiner SG; Kobayashi K; Reynolds J; Chan K; Kelly R; Wakeman S; Reddy P; Young LD
    Pain Med; 2021 Oct; 22(10):2218-2223. PubMed ID: 33561288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of Electronic Health Record Integration and Clinical Decision Support to Improve Emergency Department Prescription Drug Monitoring Program Use.
    Hoppe JA; Ledbetter C; Tolle H; Heard K
    Ann Emerg Med; 2024 Jan; 83(1):3-13. PubMed ID: 37632496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
    Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
    JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of a PDMP-EHR Data Integration Combined With Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area.
    Calcaterra SL; Butler M; Olson K; Blum J
    J Addict Med; 2022 May-Jun 01; 16(3):324-332. PubMed ID: 34392255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
    Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
    BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Integrating Access to a Prescription Drug Monitoring Program Within the Electronic Health Record on the Frequency of Queries by Primary Care Clinicians: A Cluster Randomized Clinical Trial.
    Neprash HT; Vock DM; Hanson A; Elert B; Short S; Karaca-Mandic P; Rothman AJ; Melton GB; Satin D; Markowitz R; Golberstein E
    JAMA Health Forum; 2022 Jun; 3(6):e221852. PubMed ID: 35977248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.
    Stucke RS; Kelly JL; Mathis KA; Hill MV; Barth RJ
    JAMA Surg; 2018 Dec; 153(12):1105-1110. PubMed ID: 30140927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
    Martello J; Cassidy B; Mitchell A
    J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
    Brown WC; Whitted K
    J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in Urologic Discharge Opioid Prescribing after Mandatory Query of Statewide Prescription Drug Monitoring Program.
    Myrga JM; Macleod LC; Bandari J; Jacobs BL; Davies BJ
    Urology; 2020 May; 139():84-89. PubMed ID: 32061826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
    Manders L; Abd-Elsayed A
    Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of prescription drug monitoring program to audit opioid prescribing patterns for patients with symptomatic nephrolithiasis.
    Khatun R; Galida M; Streeper NM
    Can J Urol; 2021 Feb; 28(1):10542-10546. PubMed ID: 33625345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
    Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
    Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
    Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
    J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015-2018.
    Henry SG; Shev AB; Crow D; Stewart SL; Wintemute GJ; Fenlon C; Wirtz SJ
    Prev Med; 2021 Dec; 153():106861. PubMed ID: 34687731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Are Real-time Opioid Prescribing Cognitions by Emergency Providers Influenced by Reviewing the State Prescription Drug Monitoring Program?
    Landau A; Lynch M; Callaway C; Suffoletto B
    Pain Med; 2019 May; 20(5):955-960. PubMed ID: 29762757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.
    Bao Y; Pan Y; Taylor A; Radakrishnan S; Luo F; Pincus HA; Schackman BR
    Health Aff (Millwood); 2016 Jun; 35(6):1045-51. PubMed ID: 27269021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of automatic physician review of prescription drug monitoring program data on opioid prescribing in a Maryland statewide hospital system.
    Stryckman B; Schoenbaum A; Klein J; Chasm R; Onukwugha E; Dezman ZD
    J Opioid Manag; 2022; 18(6):547-556. PubMed ID: 36523206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.